Hot Investor Mandate: Private Investment Firm Seeks to Invest in Clinical Stage Therapeutics Including Vaccines, Platform Technologies, Repurposed Drugs, Etc.

31 Mar

A private investment firm primarily invests in life sciences and disruptive technologies and is actively seeking new investment opportunities. The firm is most interested in USA-based companies, but is open to investing in other geographies given that the companies target the USA or EU markets.

The firm is most interested in therapeutics, and most of their portfolio companies have fallen in that sector thus far. The firm has reviewed medical device opportunities before, but has yet to make an investment in that space nor is that within the firm’s current focus. The firm steers away from digital health. Currently, the firm is most interested in vaccines, platform technologies, and reformulations and repurposed drugs (505(b)(2) or even ANDA regulatory pathway). For disease areas/indications, the firm is interested in infectious diseases, oncology/immuno-oncology, neurology, ophthalmology, and orphan diseases. The firm prefers to invest in clinical assets, and pre-IND assets are generally considered too early stage by the firm. For companies developing vaccines or in infectious diseases, the firm may consider earlier stage opportunities as the firm is most interested in these fields. The firm is also open to commercial stage opportunities.

The firm seeks to work with experienced management teams with a demonstrated track record of success. The firm generally co-invests alongside a syndicate and will not always seek a board seat. The firm does have strong strategic value-add, and seeks to work with their portfolio companies to help develop new R&D partnerships, commercial and licensing alliances, new drug development program collaborations, manufacturing, supply and distribution joint ventures, and more.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: